Skip to main content

Advertisement

SpringerLink
Log in

Bone and joint infections caused by Clostridium perfringens: a case series

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate antimicrobial therapy outcomes of bone and joint infections (BJI) caused by Clostridium perfringens. We investigated remission of symptoms and the absence of relapse or reinfection during follow-up. Among the 8 patients with C. perfringens BJI, the type of infection was early prosthesis infection (n = 2), osteosynthetic device infection (n = 4), and chronic osteomyeletis (n = 2). Clindamycin-rifampicin combination was given in 4 cases and metronidazole in 4 cases. The overall success rate was 87.5%. Among the 7 patients who completed antibiotic treatment, the success rate was 100%. The clindamycin-rifampicin combination appeared to be effective in patients with C. perfringens BJI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Yes. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Kiu R, Hall LJ (2018) An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect 7:1–15

    Article  CAS  Google Scholar 

  2. Brook I (2016) Spectrum and treatment of anaerobic infections. J Infect Chemother 22:1–13

    Article  Google Scholar 

  3. Gredlein CM, Silverman ML, Downey MS (2000) Polymicrobial septic arthritis due to clostridium species: case report and review. Clin Infect Dis 30:590–594

    Article  CAS  Google Scholar 

  4. Lotte R, Popoff MR, Degand N, Lotte L, Bouvet P, Baudin G et al (2014) Lumbar discitis caused by clostridium perfringens. J Clin Microbiol 52:3813–3815

    Article  Google Scholar 

  5. Rush JH (1976) Clostridial infection in total hip joint replacement: a report of two cases. ANZ J Surg 46:45–48

    Article  CAS  Google Scholar 

  6. Shah NB, Tande AJ, Patel R, Berbari EF (2015) Anaerobic prosthetic joint infection. Anaerobe 36:1–8

    Article  CAS  Google Scholar 

  7. SOCIETE FRANCAISE DE MICROBIOLOGIE. Comité de l’antibiogramme de la Société Française de Microbiologie- Recommandations 2019 V.2.0 Mai

  8. CASFM / EUCAST V2.0 Mai 2019. https://www.sfm-microbiologie.org/2019/05/06/casfm-eucast-2019-v2/

  9. Rutter WC, Burgess DS (2018) Incidence of acute kidney injury among patients treated with piperacillin-tazobactam or meropenem in combination with vancomycin. Antimicrob Agents Chemother 62:e00264–18, /aac/62/7/e00264–18.atom

  10. Stevens DL, Maier KA, Mitten JE (1987) Effect of antibiotics on toxin production and viability of clostridium perfringens. Antimicrob Agents Chemother 31:213–218

    Article  CAS  Google Scholar 

  11. Société de Pathologie Infectieuse de Langue Française (SPILF), Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT), Groupe de Pathologie Infectieuse Pédiatrique (GPIP), Société Française d’Anesthésie et de Réanimation (SFAR), Société Française de Chirurgie Orthopédique et Traumatologique (SOFCOT), Société Française d’Hygiène Hospitalière (SFHH), et al. Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis). Med Mal Infect 2009; 39:745–774

  12. Stroud G, Vandiver JW (2020) Clostridium perfringens as an unusual cause of a prosthetic joint infection following total knee arthroplasty. IDCases 20:e00789

    Article  Google Scholar 

  13. Fauser DJ, Zuckerman JD (1988) Clostridial septic arthritis: case report and review of the literature. Arthritis Rheum 31:295–298

    Article  CAS  Google Scholar 

  14. Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF (2019) Antibiotic penetration into bone and joints: an updated review. Int J Infect Dis 81:128–136

    Article  CAS  Google Scholar 

  15. Schilcher K, Andreoni F, Dengler Haunreiter V, Seidl K, Hasse B, Zinkernagel AS (2016) Modulation of Staphylococcus aureus biofilm matrix by subinhibitory concentrations of clindamycin. Antimicrob Agents Chemother 60:5957–5967

    Article  CAS  Google Scholar 

  16. Kim B-N, Kim ES, Oh M-D (2014) Oral antibiotic treatment of staphylococcal bone and joint infections in adults. J Antimicrob Chemother 69:309–322

    Article  CAS  Google Scholar 

  17. Bonnaire A, Vernet-Garnier V, Lebrun D, Bajolet O, Bonnet M, Hentzien M et al (2021) Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp. Diagn Microbiol Infect Dis 99:115225

    Article  CAS  Google Scholar 

  18. Bernard A, Kermarrec G, Parize P, Caruba T, Bouvet A, Mainardi J-L et al (2015) Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination. J Inf Secur 71:200–206

    Google Scholar 

  19. Goolsby TA, Jakeman B, Gaynes RP (2018) Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents 51:319–325

    Article  CAS  Google Scholar 

  20. Kuriyama A, Jackson JL, Doi A, Kamiya T (2011) Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharmacol 34:241–247

    Article  CAS  Google Scholar 

  21. Hernández Ceruelos A, Romero-Quezada LC, Ruvalcaba Ledezma JC, López CL (2019) Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci 23:397–401

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank Fiona Ecarnot, PhD (EA3920, University Hospital Besancon, France) for editorial assistance.

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Infectious Diseases, Reims Teaching Hospitals, Avenue du Général Koenig, 51092, Reims, France

    Margaux Visse, Maxime Hentzien & Firouzé Bani-Sadr

  2. Department of Bacteriology, Reims Teaching Hospitals, Reims, France

    Véronique Vernet-Garnier

  3. Department of Hygiene, Reims Teaching Hospitals, Reims, France

    Odile Bajolet

  4. Department of Internal Medicine and Infectious Diseases, Manchester Hospital, Charleville-Mezieres, France

    Delphine Lebrun

  5. Department of Pharmacy, Reims Teaching Hospitals, Reims, France

    Morgane Bonnet

  6. Department of Orthopedic Surgery, Reims Teaching Hospitals, Reims, France

    Xavier Ohl & Saidou Diallo

Authors
  1. Margaux Visse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Véronique Vernet-Garnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Odile Bajolet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Delphine Lebrun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Morgane Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maxime Hentzien
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xavier Ohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Saidou Diallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Firouzé Bani-Sadr
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors cared for the patients. FBS, VVG, and SD were responsible for the overall supervision of the study. MV and FBS wrote the first manuscript draft. All authors critically reviewed the manuscript and gave final approval. FBS was responsible for the overall supervision of the study.

Corresponding author

Correspondence to Firouzé Bani-Sadr.

Ethics declarations

Ethics approval

Only parameters collected in routine clinical practice for which patients give their informed consent on admission to the hospital were retrospectively analyzed. Approval by an ethics committee was not required in accordance with French legislation.

Consent to participate

Not applicable. All patients received information on the use of their data for research purpose.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Visse, M., Vernet-Garnier, V., Bajolet, O. et al. Bone and joint infections caused by Clostridium perfringens: a case series. Eur J Clin Microbiol Infect Dis 40, 2221–2225 (2021). https://doi.org/10.1007/s10096-021-04225-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-021-04225-2

Keywords

Search

Navigation